Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVS | ABBV | MRK | ||
| Company | Novartis Ag ADR | Abbvie Inc | Merck & Company | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 138.88 | 229.82 | 106.45 | ||
| High | 139.22 | 230.61 | 107.05 | ||
| Low | 138.39 | 228.68 | 106.03 | ||
| Latest | 139.18 | 229.98 | 106.78 | ||
| Change | +0.30 | +0.09 | +0.33 | ||
| % Change | +0.22% | +0.04% | +0.31% | ||
| Volume | 587,100 | 1,593,900 | 6,280,700 | ||
| 20-Day Average Volume | 1,631,740 | 5,266,475 | 14,648,285 | ||
| Previous Close | 138.88 | 229.89 | 106.45 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 133.90 | 226.12 | 101.29 | ||
| 20-Day Raw Stochastic | 91.17% | 91.04% | 97.54% | ||
| 20-Day Relative Strength | 66.92 | 54.36 | 68.41 | ||
| Weighted Alpha | +41.57 | +29.79 | +20.86 | ||
| Today's Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 80% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.89% since 12/18/25 | +3.21% since 12/18/25 | +6.05% since 12/18/25 | ||
| Low | 134.82 on 12/19/25 | 222.35 on 12/19/25 | 100.11 on 12/19/25 | ||
| High | 140.18 on 12/23/25 | 230.80 on 12/24/25 | 107.05 on 12/26/25 | ||
| 1-Month | |||||
| %Chg | +6.70% since 11/26/25 | +1.02% since 11/26/25 | +2.05% since 11/26/25 | ||
| Low | 128.91 on 12/01/25 | 220.23 on 12/09/25 | 96.06 on 12/09/25 | ||
| High | 140.18 on 12/23/25 | 230.94 on 12/04/25 | 107.05 on 12/26/25 | ||
| 3-Month | |||||
| %Chg | +12.56% since 09/26/25 | +4.25% since 09/26/25 | +35.92% since 09/26/25 | ||
| Low | 121.57 on 10/29/25 | 211.69 on 11/03/25 | 78.03 on 09/29/25 | ||
| High | 140.18 on 12/23/25 | 244.81 on 10/01/25 | 107.05 on 12/26/25 | ||
| 6-Month | |||||
| %Chg | +15.67% since 06/26/25 | +23.12% since 06/26/25 | +35.46% since 06/26/25 | ||
| Low | 112.34 on 08/01/25 | 181.73 on 06/27/25 | 76.66 on 07/29/25 | ||
| High | 140.18 on 12/23/25 | 244.81 on 10/01/25 | 107.05 on 12/26/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 294,006,912 | 406,463,200 | 265,030,400 | ||
| Shares Outstanding, K | 2,112,422 | 1,767,385 | 2,482,023 | ||
| Annual Sales | 51,722,000,000 | 56,334,000,000 | 64,168,000,000 | ||
| Annual Net Income | 11,941,000,000 | 4,278,000,000 | 17,117,000,000 | ||
| Last Quarter Sales | 14,358,000,000 | 15,776,000,000 | 17,276,000,000 | ||
| Last Quarter Net Income | 3,928,000,000 | 186,000,000 | 5,785,000,000 | ||
| 60-Month Beta | 0.52 | 0.36 | 0.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.25 on 10/28/25 | 1.86 on 10/31/25 | 2.58 on 10/30/25 | ||
| Latest Earnings Date | 01/30/26 | 01/30/26 | 02/03/26 | ||
| Most Recent Dividend | 2.596 on 03/12/25 | 1.640 on 10/15/25 | 0.850 on 12/15/25 | ||
| Next Ex-Dividends Date | 03/12/25 | 01/16/26 | 12/15/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 15.55 | 24.33 | 12.31 | ||